|
N.V. Zhukova (1), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1), N.V. Popova (1)
EXPERIENCE OF TREATMENT with ANTI-PD-1: FROM WORLD STANDARDS TO REAL CLINICAL PRACTICE (CLINICAL OBSERVATION)
|
№7 / 2018
|
|
A.V. Novik
PRINCIPLES OF MODERN IMMUNOTHERAPY
|
№7 / 2018
|
|
Yu.A. Ragulin
NEOADYAVANT THERAPY OF NON-SMALL CELL LUNG CANCER: ARE THERE ANY PERSPECTIVES?
|
№8 / 2017
|
|
I.V. Nesterova (1), S.V. Kovaleva (2), G.A. Chudilova (2), L.V. Lomtatidze (2), O.N. Shinkareva (2), V.V. Malinovskaya (3)
EFFICACY AND SAFETY OF DRUG VIFERON® IN MONOTHERAPY AND COMBINED IMMUNOTHERAPY OF IMMUNOCOMPROMISED CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS
|
№4 / 2017
|
|
I.V. Nesterova (1), S.V. Kovaleva (2), G.A. Chudilova (2), L.V. Lomtatidze (2), O.N. Shinkareva (2), V.V. Malinovskaya (3)
TACTICS OF REHABILITATION OF IMMUNOCOMPROMISED CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS: DIFFERENTIATED APPROACHES TO INTERFERONO - AND IMMUNOTHERAPY
|
№20 / 2016
|
|
E.I. Borisova, S.L. Gutorov, M.E. Abramov
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
|
№17 / 2016
|
|
M.S. Sayapina, D.A. Nosov
MODERN APPROACHES TO TREATMENT OF RENAL CELL CARCINOMA ACCORDING TO THE MATERIALS OF THE VII INTERNATIONAL CONFERENCE OF RENAL CANCER EXPERTS (CORE, 2016)
|
№8 / 2016
|
|
E.L. Savlevich, PhD in Medical Sciences
PATHOGENETIC RATIONALE FOR IMMUNOTHERAPY OF CHRONIC TONSILLITIS
|
№4 / 2015
|
|
E.L. Savlevich
PATHOGENETIC SUBSTANTIATION OF THE IMMUNOTHERAPY OF CHRONIC TONSILLITIS
|
№1 / 2015
|
Русский
